Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats

Journal of Parkinson s Disease(2021)10.3233/jpd-213016Source: DataRank Database

Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats is a research paper published in Journal of Parkinson s Disease (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.62)OA: hybridTopics (59)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Mariana Grigoruţă ORCID,Raul Y. Dagda ORCID,Bridget Martinez ORCID,Ruben K. Dagda ORCID,Emmanuel Vazquez‐Mayorga ORCID

Live enrichment

PubMed:34957950 PMC:PMC9108570 OpenAlex:https://openalex.org/W4200026211

NINDS NIH HHS

Grant: R01 NS105783

National Institutes of Health

Grant: 3R01NS105783-05S1

Regulation of Dendrite Homeostasis by PINK1 and PKA in Models of Parkinson's Disease

FWCI

0.62

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

hybridLicense: cc-by-nc

journalhttps://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213016?id=journal-of-parkinsons-disease%2Fjpd213016

publisherhttps://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213016?id=journal-of-parkinsons-disease%2Fjpd213016

publisherhttps://journals.sagepub.com/doi/pdf/10.3233/JPD-213016

publisherhttps://journals.sagepub.com/doi/full-xml/10.3233/JPD-213016

journalhttps://doi.org/10.3233/jpd-213016

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeurological Disorders and Treatments0301 basic medicine03 medical and health sciences0302 clinical medicineAnimalsColforsinDisease Models, AnimalDopaminergic NeuronsHumansLevodopaMesencephalonNeurodegenerative DiseasesParkinson DiseaseProtein KinasesRatsSubstantia Nigra

MeSH Terms

AnimalsDisease Models, AnimalColforsinHumansLevodopaMesencephalonParkinson DiseaseProtein KinasesSubstantia NigraNeurodegenerative DiseasesRatsDopaminergic Neurons

Keywords

LevodopaMedicineForskolinSubstantia nigraInternal medicineNeuroprotectionEndocrinologyPINK1DopamineParkinson's diseaseDopaminergicPharmacologyParkinDiseasePKATherapeuticsBioenergeticsParkinson’s DiseaseResearch ReportDopaminergic NeuronsColforsinNeurodegenerative DiseasesParkinson DiseaseRatsDisease Models, AnimalMesencephalonAnimalsHumansProtein Kinases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being